Submitted by Anonymous (not verified) on 29 September 2025 - 7:43
Human medicines European public assessment report (EPAR): Xalkori, crizotinib, Date of authorisation: 23/10/2012, Revision: 39, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Xalkori, crizotinib, Date of authorisation: 23/10/2012, Revision: 39, Status: Authorised